Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination

Jennifer L. Moss, Melissa B. Gilkey, Barbara K. Rimer, Noel T. Brewer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

ABSTRACT: Background. Healthcare providers may vary their communications with different patients, which could give rise to differences in vaccination coverage. We examined demographic disparities in parental report of collaborative provider communication and implications for human papillomavirus (HPV) vaccination. Methods. Participants were 4,124 parents who completed the National Immunization Survey-Teen about daughters ages 13–17. We analyzed disparities in collaborative communication (mutual information exchange, deliberation, and decision) and whether they mediated the relationship between demographic characteristics and HPV vaccine initiation. Results. Half of parents (53%) in the survey reported collaborative communication. Poor, less educated, Spanish-speaking, Southern, and rural parents, and parents of non-privately insured and Hispanic adolescents, were least likely to report collaborative communication (all p<.05). These disparities in communication accounted for geographic variation in HPV vaccination, specifically, the higher rates of uptake in the Northeast versus the South (mediation z=2.31, p<.01) and in urban/suburban vs. rural areas (mediation z=2.87, p<.01). These disparities were also associated with vaccination among subgroups with relatively high coverage, minimizing what could have been even higher uptake among Hispanic compared to non-Hispanic white adolescents (mediation z=−3.04, p<.01) and non-privately versus privately insured adolescents (mediation z=−3.67, p<.001). Controlling for provider recommendation attenuated some of these associations (but all p<.10). Conclusions. Collaborative communication showed widespread disparities, being least common among underserved groups. Collaborative communication helped account for differences—and lack of differences—in HPV vaccination among some subgroups of adolescent girls. Leveraging patient-provider communication, especially for underserved demographic groups, could improve HPV vaccination coverage.

Original languageEnglish (US)
Pages (from-to)1476-1483
Number of pages8
JournalHuman Vaccines and Immunotherapeutics
Volume12
Issue number6
DOIs
StatePublished - Jun 2 2016

Fingerprint

Vaccination
Communication
Parents
Demography
Hispanic Americans
Papillomavirus Vaccines
Nuclear Family
Health Personnel
Immunization

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Moss, Jennifer L. ; Gilkey, Melissa B. ; Rimer, Barbara K. ; Brewer, Noel T. / Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination. In: Human Vaccines and Immunotherapeutics. 2016 ; Vol. 12, No. 6. pp. 1476-1483.
@article{7cbeabd3561344b9a19eadf3b64023c6,
title = "Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination",
abstract = "ABSTRACT: Background. Healthcare providers may vary their communications with different patients, which could give rise to differences in vaccination coverage. We examined demographic disparities in parental report of collaborative provider communication and implications for human papillomavirus (HPV) vaccination. Methods. Participants were 4,124 parents who completed the National Immunization Survey-Teen about daughters ages 13–17. We analyzed disparities in collaborative communication (mutual information exchange, deliberation, and decision) and whether they mediated the relationship between demographic characteristics and HPV vaccine initiation. Results. Half of parents (53{\%}) in the survey reported collaborative communication. Poor, less educated, Spanish-speaking, Southern, and rural parents, and parents of non-privately insured and Hispanic adolescents, were least likely to report collaborative communication (all p<.05). These disparities in communication accounted for geographic variation in HPV vaccination, specifically, the higher rates of uptake in the Northeast versus the South (mediation z=2.31, p<.01) and in urban/suburban vs. rural areas (mediation z=2.87, p<.01). These disparities were also associated with vaccination among subgroups with relatively high coverage, minimizing what could have been even higher uptake among Hispanic compared to non-Hispanic white adolescents (mediation z=−3.04, p<.01) and non-privately versus privately insured adolescents (mediation z=−3.67, p<.001). Controlling for provider recommendation attenuated some of these associations (but all p<.10). Conclusions. Collaborative communication showed widespread disparities, being least common among underserved groups. Collaborative communication helped account for differences—and lack of differences—in HPV vaccination among some subgroups of adolescent girls. Leveraging patient-provider communication, especially for underserved demographic groups, could improve HPV vaccination coverage.",
author = "Moss, {Jennifer L.} and Gilkey, {Melissa B.} and Rimer, {Barbara K.} and Brewer, {Noel T.}",
year = "2016",
month = "6",
day = "2",
doi = "10.1080/21645515.2015.1128601",
language = "English (US)",
volume = "12",
pages = "1476--1483",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",
number = "6",

}

Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination. / Moss, Jennifer L.; Gilkey, Melissa B.; Rimer, Barbara K.; Brewer, Noel T.

In: Human Vaccines and Immunotherapeutics, Vol. 12, No. 6, 02.06.2016, p. 1476-1483.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination

AU - Moss, Jennifer L.

AU - Gilkey, Melissa B.

AU - Rimer, Barbara K.

AU - Brewer, Noel T.

PY - 2016/6/2

Y1 - 2016/6/2

N2 - ABSTRACT: Background. Healthcare providers may vary their communications with different patients, which could give rise to differences in vaccination coverage. We examined demographic disparities in parental report of collaborative provider communication and implications for human papillomavirus (HPV) vaccination. Methods. Participants were 4,124 parents who completed the National Immunization Survey-Teen about daughters ages 13–17. We analyzed disparities in collaborative communication (mutual information exchange, deliberation, and decision) and whether they mediated the relationship between demographic characteristics and HPV vaccine initiation. Results. Half of parents (53%) in the survey reported collaborative communication. Poor, less educated, Spanish-speaking, Southern, and rural parents, and parents of non-privately insured and Hispanic adolescents, were least likely to report collaborative communication (all p<.05). These disparities in communication accounted for geographic variation in HPV vaccination, specifically, the higher rates of uptake in the Northeast versus the South (mediation z=2.31, p<.01) and in urban/suburban vs. rural areas (mediation z=2.87, p<.01). These disparities were also associated with vaccination among subgroups with relatively high coverage, minimizing what could have been even higher uptake among Hispanic compared to non-Hispanic white adolescents (mediation z=−3.04, p<.01) and non-privately versus privately insured adolescents (mediation z=−3.67, p<.001). Controlling for provider recommendation attenuated some of these associations (but all p<.10). Conclusions. Collaborative communication showed widespread disparities, being least common among underserved groups. Collaborative communication helped account for differences—and lack of differences—in HPV vaccination among some subgroups of adolescent girls. Leveraging patient-provider communication, especially for underserved demographic groups, could improve HPV vaccination coverage.

AB - ABSTRACT: Background. Healthcare providers may vary their communications with different patients, which could give rise to differences in vaccination coverage. We examined demographic disparities in parental report of collaborative provider communication and implications for human papillomavirus (HPV) vaccination. Methods. Participants were 4,124 parents who completed the National Immunization Survey-Teen about daughters ages 13–17. We analyzed disparities in collaborative communication (mutual information exchange, deliberation, and decision) and whether they mediated the relationship between demographic characteristics and HPV vaccine initiation. Results. Half of parents (53%) in the survey reported collaborative communication. Poor, less educated, Spanish-speaking, Southern, and rural parents, and parents of non-privately insured and Hispanic adolescents, were least likely to report collaborative communication (all p<.05). These disparities in communication accounted for geographic variation in HPV vaccination, specifically, the higher rates of uptake in the Northeast versus the South (mediation z=2.31, p<.01) and in urban/suburban vs. rural areas (mediation z=2.87, p<.01). These disparities were also associated with vaccination among subgroups with relatively high coverage, minimizing what could have been even higher uptake among Hispanic compared to non-Hispanic white adolescents (mediation z=−3.04, p<.01) and non-privately versus privately insured adolescents (mediation z=−3.67, p<.001). Controlling for provider recommendation attenuated some of these associations (but all p<.10). Conclusions. Collaborative communication showed widespread disparities, being least common among underserved groups. Collaborative communication helped account for differences—and lack of differences—in HPV vaccination among some subgroups of adolescent girls. Leveraging patient-provider communication, especially for underserved demographic groups, could improve HPV vaccination coverage.

UR - http://www.scopus.com/inward/record.url?scp=84963604822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963604822&partnerID=8YFLogxK

U2 - 10.1080/21645515.2015.1128601

DO - 10.1080/21645515.2015.1128601

M3 - Article

C2 - 26786888

AN - SCOPUS:84963604822

VL - 12

SP - 1476

EP - 1483

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 6

ER -